Scientific Title: Do microglia prevent seizure-induced cardiorespiratory dysfunction?Lead investigator: Professor Nicholas Dale, University of WarwickCo-investigators: Dr Amol Bhandare, University of WarwickProject grant: £172,218, 2 years“Anaesthesia depresses neural activity, therefore being able to image the brainstem cardiorespiratory neuronal network and beneficial effects of microglial activation or inhibition during seizures in freely behaving animals offers therapeutic strategies to prevent cardiorespiratory failure and sudden deaths in epilepsy. This will improve the quality of life of people suffering from epilepsy by lessening concerns over SUDEP.” Professor Nicholas Dale, University of WarwickBackgroundEpileptic seizures can stop a person’s breathing or the heart from beating. This is believed to be the basis of sudden unexpected death in epilepsy (SUDEP). SUDEP is both untreatable and unpredictable, and accounts for approximately 600 deaths each year in the UK. The underlying mechanisms of cardiorespiratory arrest is unknown, but increasing evidence implicates a type of brain cell – the microglia – in this process. However, it is not clear whether these cells cause or prevent seizures associated with SUDEP.The StudyProfessor Dale and Dr Bhandare at the University of Warwick are using highly advanced head mounted mini-cameras to image cardiorespiratory brainstem neurons in animal models of epilepsy. Their expertise will allow them to address the role of microglia in SUDEP by imaging cardiorespiratory neurons, manipulating microglia and simultaneously measuring epileptic seizures. They hope to be able to prevent the failure of cardiorespiratory neuronal networks during seizures through altering microglial activity.SignificanceThe findings will establish the functional changes in specific cardiorespiratory cells in response to acute seizures, and how their role changes during the development of chronic epilepsy. This project will demonstrate the importance of microglia in regulating cardiorespiratory function in epilepsy, and will increase understanding of the mechanisms underlying SUDEP. The findings of this study could also provide biomarker tests for people with epilepsy who are at a higher risk of SUDEP. The knowledge gained in this project may lead to a potential therapeutic intervention for SUDEP based around an existing drug known to affect microglia (minocycline).